WikiPatents - Community Patent Review
Create Free Account  |  License or Sell Your Patent  |  WikiPatents Marketplace  |  WikiPatents Blog
Username:  Password:  
    
Advanced Search
Methods and apparatus for DNA sequencing    

Get related patents on CD
United States Patent5674743   
Link to this pagehttp://www.wikipatents.com/5674743.html
Inventor(s)Ulmer; Kevin M. (Cohasset, MA)
AbstractThe present invention provides a method and apparatus for automated DNA sequencing. The method of the invention includes the steps of: a) using a processive exonuclease to cleave from a single DNA strand the next available single nucleotide on the strand; b) transporting the single nucleotide away from the DNA strand; c) incorporating the single nucleotide in a fluorescence-enhancing matrix; d) irradiating the single nucleotide to cause it to fluoresce; e) detecting the fluorescence; f) identifying the single nucleotide by its fluorescence; and g) repeating steps a) to f) indefinitely (e.g., until the DNA strand is fully cleaved or until a desired length of the DNA is sequenced). The apparatus of the invention includes a cleaving station for the extraction of DNA from cells and the separation of single nucleotides from the DNA; a transport system to separate the single nucleotide from the DNA and incorporate the single nucleotide in a fluorescence-enhancing matrix; and a detection station for the irradiation, detection and identification of the single nucleotides. The nucleotides are advantageously detected by irradiating the nucleotides with a laser to stimulate their natural fluorescence, detecting the fluorescence spectrum and matching the detected spectrum with that previously recorded for the four nucleotides in order to identify the specific nucleotide.
   














 Title Information Submit all comments and votes
 
Patent Text Patent PDF Print Page Summary File History
Plain text PDF images Print Summary File History Custom Search
Inventor     Ulmer; Kevin M. (Cohasset, MA)
Owner/Assignee     SEQ, Ltd. (Princeton, NJ)
Patent assignment
All assignments
Company News
Publication Date     October 7, 1997
Application Number     08/463,831
PAIR File History     Application Data   Transaction History
Image File Wrapper   Patent Term   Fees
Litigation
Filing Date     June 5, 1995
US Classification     435/287.2 422/82.08 435/288.7 436/94 436/172
Int'l Classification     C12M 003/00
Examiner     Redding; David A.
Assistant Examiner    
Attorney/Law Firm     Pennie & Edmonds
Address
Parent Case     This is a division of application Ser. No. 08/376,761, filed Jan. 23, 1995, which is a continuation of application Ser. No. 08/012,862 filed Feb. 1, 1993 now abandoned.
Priority Data    
USPTO Field of Search     435/287.2 435/288.7 422/82.08 436/94 436/172
Patent Tags     methods dna sequencing
   
Enter a comma (,) or semicolon (;) between multiple tag words/phrases.
Describe this patent:
 Amusing   
 Clever   
 Complex   
 Efficient   
 Historic   
 Important   
 Innovative   
 Interesting   
 Practical   
 Simple   
[no votes]
Patent WIKI

Share information and news about this patent, including information and news about the technology, inventors, company, ligation and licensing.

 References Submit all comments and votes
 
*references marked with an asterisk below are user-added references
 U.S. References
 
Add a new US reference:  
ReferenceRelevancyCommentsReferenceRelevancyComments
3872312



[0 after 0 votes]
5547839
Dower
435/6
Aug,1996

[0 after 0 votes]
5405747
Jett
435/6
Apr,1995

[0 after 0 votes]
5374527
Grossman
204/451
Dec,1994

[0 after 0 votes]
5322796
Ishikawa
436/94
Jun,1994

[0 after 0 votes]
5288644
Beavis
436/94
Feb,1994

[0 after 0 votes]
5171534
Smith
204/612
Dec,1992

[0 after 0 votes]
5079169
Chu

Jan,1992

[0 after 0 votes]
4983038
Ohki
356/246
Jan,1991

[0 after 0 votes]
4962037
Jett
435/6
Oct,1990

[0 after 0 votes]
4893886
Ashkin
359/350
Jan,1990

[0 after 0 votes]
4889818
Gelfand
435/194
Dec,1989

[0 after 0 votes]
4863849
Melamede
435/6
Sep,1989

[0 after 0 votes]
4795699
Tabor
435/5
Jan,1989

[0 after 0 votes]
4793705
Shera
356/318
Dec,1988

[0 after 0 votes]
4676274
Brown
137/806
Jun,1987

[0 after 0 votes]
4166105
Hirschfeld
436/536
Aug,1979

[0 after 0 votes]
4683202
Mullis
435/91.2
Dec,1969

[0 after 0 votes]
4683195
Mullis
435/6
Dec,1969

[0 after 0 votes]
 Foreign References
 Other References
 Market Review Submit all comments and votes
   
Market Size
Estimate the gross annual revenues of the relevant market sector:
> $10B
$5B - $10B
$2B - $5B
$500M - $2B
$100M - $500M
$10M - $100M
$1M - $10M
$500K - $1M
$100K - $500K
< $100K
[No votes]
$0
 
$0   $2.5B   $5B   $7.5B   $10B

[0 market size comments]
Market Share
Estimate the percentage of the relevant market sector this invention will capture:
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%

[0 market share comments]
Reasonable Royalty
What percentage of gross sales should the inventor or assignee be paid?
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%

[0 reasonable royalty comments]
Public's "Guesstimation" of Royalty Value
Market SizeN/A[No votes]
xMarket ShareN/A[No votes]
xReasonable RoyaltyN/A[No votes]

N/A

[0 Guesstimation of Royalty Value Comments]
License Availablity
If you are NOT the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
[0 license availability comments]
License Availablity
If you ARE the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
[0 owner/assignee comments]
Competitive Advantage
Does this invention have a significant competitive advantage over similar technologies?
Yes

No



[No votes]
Most helpful competitive advantage comment
[No comments]

[0 competitive advantage comments]
Commercial Alternatives
Are there viable commercial alternatives for this invention?
Yes

No



[No votes]
Most helpful commercial alternative comment
[No comments]

[0 commercial alternatives comments]
 Technical Review Submit all comments and votes
 Claims Submit all comments and votes
 


What is claimed is:

1. A genome sequencer comprising:

means for sequentially separating single nucleotides from a strand of DNA;

means for confining the separated nucleotides in their original sequence in a solid matrix;

means for exciting each separated nucleotide;

means for detecting the spectroscopic emission of each separated nucleotide; and

means for identifying each separated nucleotide according to its spectroscopic emission.

2. The genome sequencer according to claim 1 wherein means for exciting each separated nucleotide includes a laser system.

3. The genome sequencer according to claim 2 wherein the laser system includes a mode-locked laser.

4. The genome sequencer according to claim 3 wherein the mode-locked laser operates in tunable wavelength region from approximately 240 nm to 300 nm.

5. The genome sequencer method according to claim 4 wherein the mode-locked laser operates at a repetition rate of 76 MHz.

6. The genome sequencer according to claim 5 wherein the mode-locked laser operates with a pulse width of approximately one picosecond.

7. The genome sequencer according to claim 1 wherein means for detecting the spectroscopic emission of each separated nucleotide includes means for measuring by single photon counting the fluorescence spectrum of each separated nucleotide.

8. The genome sequencer according to claim 7 wherein means for measuring by single photon counting the fluorescence spectrum of each separated nucleotide includes a monochromator.

9. The genome sequencer according to claim 7 further comprising means for time gating the single photon counting.

10. The genome sequencer according to claim 1 wherein means for detecting the spectroscopic emission of each separated nucleotide includes means for measuring by single photon counting the fluorescence lifetime of each separated nucleotide.

11. The genome sequencer according to claim 10 further comprising means for time correlating the single photon counting.

12. The genome sequencer according to claim 11 wherein means for time correlating includes a time-to-amplitude converter.

13. The genome sequencer according to claim 12 wherein means for time correlating further includes a multi-channel analyzer.

14. The genome sequencer according to claim 1 wherein means for detecting includes a micro-channel plate photomultiplier.

15. The genome sequencer according to claim 1 wherein means for detecting includes a single-photon avalanche diode.

16. The genome sequencer according to claim 1 10 wherein means for detecting includes a streak camera.

17. The genome sequencer according to claim 1 further comprising optical fibers for collecting the spectroscopic emission.

18. A genome sequencer comprising:

(a) means for sequentially separating single nucleotides from a strand of DNA in the order of the original sequence of said nucleotides in said strand; and

(b) a refrigeration system capable of cooling a solution containing said separated nucleotides to a temperature sufficient to vitrify the solution containing said separated nucleotides.

19. The genome sequencer according to claim 18 wherein the means for separating includes an optical trap suitable for positioning a microsphere to which said strand of DNA is affixed.

20. The genome sequencer according to claim 18 wherein the means for separating includes means for depositing said separated nucleotides on a solid support.

21. The genome sequencer according to claim 18 wherein the means for separating includes (i) an optical trap suitable for positioning a microsphere to which said strand of DNA is affixed; and (ii) means for depositing said separated nucleotides on a transparent support in a thin continuous liquid film or as discrete droplets; said sequencer further comprising a radiation source for irradiating said nucleotides so as to cause said nucleotides to fluoresce, and means for moving said support from a first position where said nucleotides are cooled by said refrigeration system to a second position where said nucleotides are irradiated by said radiation source.

22. The genome sequencer according to claim 21 further comprising means for detecting fluorescence of said nucleotides.

23. The genome sequencer according to claim 18 further comprising a radiation source for irradiating the nucleotides so as to cause said nucleotides to fluoresce.

24. The genome sequencer according to claim 23 further comprising means for detecting fluorescence of said nucleotides.

25. A genome sequencer comprising:

(a) a sheath, laminar flow microchannel;

(b) means for regulating flow through the microchannel so as to achieve hydrodynamic focusing; and

(c) a refrigeration system capable of imposing a temperature gradient over the microchannel, sufficient to vitrify an aqueous solution within said microchannel.

26. The genome sequencer of claim 1 wherein the means for separating includes an optical trap suitable for positioning a microsphere to which said strand of DNA is affixed.

27. The genome sequencer according to claim 1 wherein the means for separating includes means for fixing said separated nucleotides in a solid support.
 Description Submit all comments and votes
 


1. INTRODUCTION

Considerable interest has been developing in the past few years to sequence the entire human genome (i.e., all of the genetic material in a human cell). The task, however, is enormous because it involves the sequencing of at least 3,000,000,000 base pairs, an effort which is likely to take ten or more years and cost $3,000,000,000 if undertaken using conventional technology (1993 Edgington, Bio/Technology 11:39-42, which is incorporated herein by reference).

The Committee on Mapping and Sequencing the Human Genome of the National Research Council in their 1988 report entitled, Mapping and Sequencing the Human Genome (which is incorporated herein by reference), stated that, "No foreseeable technology will be able to automate DNA sequencing comprehensively." The present invention is a method and apparatus for comprehensively automating this effort with substantial improvements in speed and cost. The invention is applicable to the sequencing of genetic material from any source, human or otherwise.

2. BACKGROUND OF THE INVENTION

2.1. DNA AND RNA

Deoxyribonucleic acid (DNA) is the primary genetic material of most organisms. Ribonucleic acid (RNA) is the primary genetic material in certain viruses. Additionally, a form of RNA known as messenger RNA (mRNA) is found in all cells and comprises copies of portions of the primary genetic information found in the DNA. In its natural state, DNA is found in the form of a pair of complementary chains of nucleotides which are interconnected as a double helix (see FIG. 1). A nucleotide in turn is compesed of a nitrogenous base (see FIGS. 2 and 3), which identifies the nucleotide, linked by an N-glycosidic bond to a five-carbon sugar. RNA differs from DNA in that in DNA the nucleotide sugar is deoxyribose, while in RNA, the sugar is ribose. A phosphate group serves to link the nucleotides together, formihg the backbone of a single strand of DNA (see FIG. 2). Normally, the nitrogenous base is one of the following: adenine, guanine, thymine and cytosine (respectively denoted A, G, T, and C), or uracil (U) in place of thymidine in RNA (see FIG. 3). The order of the four nucleotides, A, G, T and C, in the chain is often referred to as the sequence of the DNA and can be specified simply by setting down the symbols A, G, T and C in the order in which these four nucleotides appear in the DNA strand.

The two chains (or strands) of a DNA double helix are held together by hydrogen bonding between the nitrogenous bases of their individual nucleotides. This hydrogen bonding is specific in-that adenine in one strand must pair with thymine (or uracil in RNA) in the other strand, and guanine with cytosine. The sequence of bases in one strand of DNA is thus complementary to the sequenceon the other strand.

A DNA chain has polarity: one end of the chain has a free 5'--OH (or phosphate) group (termed "the 5' end") and the other a free 3'--OH (or phosphate) group ("the 3' end"). By convention, the nucleotide sequence is written or read left-to-right in the direction from the 5' end to the 3' end. The two strands of a DNA double helix have opposite polarities. Thus the 5' end of one strand pairs with the 3' end of the Other strand and the complementarity of the two strands is revealed by comparing one strand read,in the 5' to 3' direction with the other strand read in the 3' to 5' direction.

Genetic information is encoded in the particular sequence (order of occurrence) of nucleotides along a DNA molecule and DNA sequencing is the process of determining that order in a particular DNA molecule.

2.2. ENZYMES USED IN DNA SEQUENCING

Two classes of enzyme activity which have been employed in certain methods used to sequence DNA are DNA polymerase and exonuclease activity.

A DNA polymerase is an enzyme that has the ability to catalytically synthesize new strands of DNA in vitro. The DNA polymerase carries out this synthesis by moving along a preexisting single DNA strand ("the template") and creating a new strand, complementary to the preexisting strand, by incorporating single nucleotides one at a time into the new strand following the base-pairing rule described above.

In contrast to polymerase activity, exonuclease activity refers to the ability of an enzyme (an exonuclease) to cleave off a nucleotide at the end of a DNA strand. Enzymes are known which can cleave successive nucleotides in the single DNA strand of a single-chain DNA molecule, working from the 5' end of the strand to the 3' end; such enzymes are termed single-stranded 5' to 3' exonucleases. Other enzymes are known which perform this operation in the opposite direction (single-stranded 3' to 5' exonucleases). There also exist enzymes which can cleave successive nucleotides from the end of a single strand of a double-stranded DNA molecule. These enzymes are termed double-stranded 5' to 3' or 3' to 5' exonucleases, depending on the direction in which they proceed along the strand. Exonucleases are also characterized as being distributive or processive in their action. Distributive exonucleases dissociate from the DNA following each internucleotide bond cleavage, whereas processive exonucleases will hydrolyze many internucleotide bonds without dissociating from the DNA.

2.3. SEQUENCING OF DNA

Approaches to DNA sequencing have varied widely. Use of these enzymes or other chemical methods, as described below, has made it possible to sequence small portions of the human genome. Despite these successes, most of the human genome remains unexplored. Of the 3,000,000,000 base pairs in the human genome, only about 20 million base pairs have been sequenced (GenBank.RTM. Release 74--December 1992).

2.3.1. SEQUENCING LADDER METHODS

Many techniques for sequencing DNA have involved generating fragments of labeled DNA, the lengths of which are sequence-dependent, and separating the fragments according. to their lengths by electric field-induced migration in a gel, so as to be able to discern the DNA sequence from the appearance of the separated fragments. Such a pattern of sequence-dependent fragment lengths is known as a sequencing ladder. The fragments can be generated by either: (a) cleaving the DNA in a base-specific manner (see FIG. 4), or (b) synthesizing. a copy of the DNA wherein the synthesized strand terminates in a base-specific manner (see FIG. 5).

The Maxam-Gilbert technique for sequencing (Maxam and Gilbert, 1977, Proc. Natl. Acad. Sci. USA 74:560, which is incorporated herein by reference) involves the specific chemical cleavage of DNA. According to this technique, four samples of the same labeled DNA are each subjected to a different chemical reaction to effect preferential cleavage of the DNA molecule at one or two nucleotides of a specific base identity. By adjusting the conditions to obtain only partial cleavage, DNA fragments are thus generated in each sample whose lengths are dependent upon the position within the DNA ba.se sequence of the nucleotide(s) which are subject to such cleavage. Thus, after partial cleavage is performed, each sample contains DNA fragments of different lengths each of which ends with the same one or two of the four nucleotides. In particular, in one sample each fragment ends with a C, in another sample each fragment ends with a C or a T, in a third sample each ends with a G, and in a fourth sample each ends with an A or a G. The fragments so generated are then separated from one another by electric field-induced migration in a polyacrylamide gel. The four individual sets of fragments produced by cleavage using chemical reactions of different specificity are run side-by-side, in separate lanes of the gel. The DNA fragments are then visualized, and sequence is determined by the observing the position in the gel of the generated fragments.

FIG. 4 schematically depicts the visualization of DNA fragments that are generated by cleaving the labelled DNA having the sequence 5'-AAGTACT-3'-label. The fragments from the four samples are run side-by-side in the four lanes of the gel identified by G, A+G, C, T+C where G identifies the sample in which all the fragments end with guanine nucleotides, A+G identifies the sample in which all the fragments end with either an adenine or a guanine nucleotide, C identifies the sample in which all the fragments end with a cytosine nucleotide, and T+C identifies the sample in which all the fragments end with either a thymine or a cytosine nucleotide. The distance the fragments migrate in the gel is a monotonic function of their length. Thus, after the migrating fragments are visualized, the order of the nucleotides in the labelled DNA molecule can be read directly from the vertical position of the fragments in the gel. The fragments that end with adenine that appear in the A+G lane, and the fragments that end with thymine that appear in the T+C lane, can be distinguished from the fragments in the same lanes that end with guanine and cytosine, respectively, by noting that the fragments that end with guanine and cytosine also appear at the same vertical position in the G and C lanes, respectively.

In the DNA of many organisms, a significant fraction of the cytosines are methylated in vivo at the 5 position to give 5-methylcytosine. Such methylation is involved in the regulation of gene expression and in genetic imprinting. Church and Gilbert (1984, Proc. Natl. Acad. Sci. USA 81:1991-1995; incorporated herein by reference) and Saluz and Jost (1987, "A Laboratory Guide to Genomic Sequencing," BioMethods, Vol. 1, Birkhauser, Boston; incorporated herein by reference) devised a modification of the Maxam and Gilbert chemical cleavage method to provide a means for directly determining the position of 5-methylcytosine in genomic DNA. In this method, genomic DNA is chemically cleaved, then completely digested with a restriction enzyme and separated by gel electrophoresis, resulting in a complex mixture of superimposed sequencing ladders. The DNA bands forming the rungs of the sequencing ladder are next transferred and cross linked to a nylon membrane. A specific ladder from the mixture is then recognized by hybridizing the membrane with a labeled oligonucleotide probe which uniquely recognizes the sequence immediately adjacent to a particular restriction site. Frommet et al. (1992, Proc. Natl. Acad. Sci. USA 89:1827-1831, which is incorporated herein by reference) have recently developed an alternative genomic DNA sequencing method wherein cytosines in the sample DNA are converted to uracil by bisulfite treatment which leaves 5-methylcytosine unmodified. Comparison of the sequence of modified and unmodified DNA reveals the positions in the sequence of 5'-methylcytosine. Such genomic sequencing methods can only be carried out with genomic DNA. The methylation pattern is lost during gene cloning in microorganisms in vivo, and during DNA copying or amplification in vitro.

The plus/minus DNA sequencing method (Sanger and Coulson, 1975, J. Mol. Biol. 94:441-448, which is incorporated herein by reference) involves: (a) use of DNA polymerase to generate.complementary .sup.32 P-labeled DNA oligonucleotides of different.lengths; (b) (the "minus" system) in four separate reaction vessels, reaction of one half of the generated DNA with DNA polymerase and three out of the four nucleotide precursors; and (c) (the "plus" system) in four separate reaction vessels, reaction of the remaining half of the generated DNA with DNA polymerase and only one of each of the four nucleotide precursors. Each reaction mixture generated in steps (b) and (c) is subjected to a denaturing polyacrylamide gel electrophoresis. The generated fragments are separated from one another by migration in the polyacrylamide gel; the shorter the fragment, the greater the migration. After visualization of the DNA in the gel by detection of its label, the sequence of the DNA can be determined by observing the position in the gel of the generated fragments.

The dideoxy method of sequencing was published in 1977 by Sanger and his colleagues (Sanger et al., 1977, Proc. Natl. Acad. Sci. USA 74:5463, which is incorporated herein by reference). In contrast to the method of Maxam and Gilbert which relies on specific chemical cleavage to generate fragments with lengths which are sequence-dependent, the Sanger dideoxy method relies on enzymatic activity of a DNA polymerase to synthesize fragments with lengths that are sequence-dependent. The Sanger dideoxy method utilizes an enzymatically active fragment of the DNA polymerase termed E. coli DNA polymerase I, to carry out the enzymatic synthesis of new DNA strands. The newly synthesized DNA strands consist of fragments of sequence-dependent length, generated through the use of inhibitors of the DNA polymerase which cause base-specific termination of synthesis. Such inhibitors are dideoxynucleotides which, upon their incorporation by the DNA polymerase, destroy the ability of the enzyme to further elongate the DNA chain due to their lack of a suitable 3'--OH necessary in the elongation reaction. When a dideoxy nucleotide whose base can appropriately hydrogen bond with the template DNA is thus incorporated by the enzyme, synthesis of the growing DNA strand halts. Thus DNA fragments are generated by the DNA polymerase, the lengths of which are dependent upon the position within the DNA base sequence of the nucleotide whose base identity is the same as that of the incorporated dideoxynucleotide. The fragments so generated can then be separated in a gel as in the Maxam-Gilbert procedure, visualized, and the sequence determined.

For example, for the case of a template DNA molecule having the sequence 5'-GCCATCG-3'-label, FIG. 5 depicts the visualization of the DNA fragments that are generated by the dideoxy method after terminating synthesis at each of the nucleotides G, A, C and T. Since the distance a fragment migrates in the gel is a monotonic function of its length, the sequence of the DNA molecule can be read directly from the gel after the fragments are visualized.

Sanger and colleagues utilized an E. coli DNA polymerase I fragment termed the Klenow fragment. After the disclosure of the original Sanger dideoxy technique, the enzyme used in most dideoxy sequencing was the Klenow fragment. Other enzymes with DNA polymerase activity that have been used in sequencing include AMV reverse transcriptase and T7 DNA polymerase Tabor and Richardson, U.S. Pat. No. 4,795,699, which is incorporated herein by reference).

DNA sequencing methods have been automated to varying degrees. In the manual methods, radioactive labels suchas .sup.32 P are typically used identify the bands of the sequencing ladder by autoradiographic imaging on X-ray film. Digital imaging systems and pattern recognition software have been developed by several groups for automatic interpretation and data entry from such autoradiographs (Elder et al., 1986, Nucl. Acids Res. 14:417-424, which is incorporated herein by reference). Real-time recording of the sequencing ladder during gel electrophoresis was made possible by positioning .beta.-emission detectors at the bottom of the gel (EG&G Biomolecular ACUGEN.TM. Sequencer, Acugen.TM. System Report 88-106, EG&G Biomolecular), or by employing fluorescent labeling techniques in combination with real-time fluorescence detection during electrophoresis. Smith et al. (1986, Nature 321:674, which is incorporated herein by reference) disclose a method for partial automation of DNA sequencing, which involves use of four different color fluorophores bound to the primer (Smith et al., 1985, Nucl. Acids Res. 13:2399-2412, which is incorporated herein by reference) used for synthesis in one of four reaction vessels, each containing a different dideoxynucleotide in the Sanger dideoxy method. The reaction mixtures are combined and subjected to electrophoresis, during which the separated DNA fragments are identified by a fluorescent detection apparatus, and the sequence information acquired directly by computer. In an alternative approach, the dideoxy nucleotide chain terminators have each been chemically linked to different succinylfluorescein fluorescent dyes which can be distinguished by their fluorescent emission, allowing the four sequencing reactions to be run in a single tube (Prober et al., 1987, Science 238:336, which is incorporated herein by reference). Japanese scientists and engineers are participating in the development of a completely automated DNA sequencing system, employing the Sanger dideoxy method of sequencing (Endo et al., 1991, Nature 352:89-90; Wada et al., 1987, Nature 325:771-772, which are incorporated herein by reference).

Ladder-based sequencing methods are currently the most widely utilized, and variations on the Sanger method of generating the sequencing ladder are used predominantly. The throughput and cost of ladder-based sequencing methods are currently limited by three major factors: (1) the number of resolvable bases in a single ladder, (2) the time required to separate the fragments and generate the ladder, and (3) the number of ladders which can be run in parallel. Numerous efforts are presently underway to further improve each of these aspects and to thereby enhance the performance of ladder-based sequencing methods. Conventional DNA sequencing gels are typically .about.300-500 micrometers thick. With such gels it is usually possible to obtain 300-500 bases of sequence from a single sequencing ladder. The limit depends on the ability to resolve a band containing fragments which are N nucleotides long from those containing fragments which are N+1 or N-1 nucleotides in length. Increased resolution can be achieved by employing thinner gels, typically .about.25-100 micrometer, either in ultrathin slab gels (Kostichka et al., 1992, Bio/Technology 10:78-81) or in capillary gels (Drossman et al., 1990, Anal. Chem. 62:900-903, which are incorporated herein by reference). It has recently been demonstrated that such gels are capable of resolving >1,000 bases, and further improvements are projected to achieve .about.2,000 bases. One approach to further increase the resolution of the gel is to employ programmed pulse-field techniques (C. Turmel, E. Brassard, R. Forsyth, J. Randell, D. Thomas, J. Noolandi (1992) "Sequencing up to 800 bases manually using pulsed field", IN: Genome Mapping & Sequencing, Cold Spring Harbor Laboratory, Abstract #112; C. Turmel, E. Brassard, J. Noolandi (1992) Electrophoresis (in press), which are incorporated herein by reference). Because ultrathin gels can be cooled more efficiently, they can be operated at much higher voltages per unit length, thereby reducing the time required to effect the separation of the sequencing ladder. Multiple capillaries can be run in parallel or a greater number of samples can be loaded in slab gels to further increase throughput. Both capillary and ultrathin slab gels have been demonstrated to have some degree of reusability. In order to achieve the improved performance offered by ultrathin gels, it is necessary to reduce the number of DNA molecules loaded onto the gel, which therefore reduces the number of the DNA molecules in each band or rung of the sequencing ladder. This requires more sensitive detection methods which have included the use of sheath-flow cuvette fluorescence techniques (1991 Chen et al., SPIE Vol. 1435, Optical Methods for Ultrasensitive Detection and Analysis: Techniques and Applications, p. 161-167, which is incorporated herein by reference), confocal fluorescence microscopy (1992 Mathies and Huang, "Capillary array electrophoresis: an approach to high-speed, high throughput DNA sequencing," Nature 359:167-169, which is incorporated herein by reference), mass spectrometry (1990 T. Brennan, J. Chakel, P. Bente, M. Field, "New Methods to Sequence DNA by Mass Spectrometry," SPIE Vol. 1206, New Technologies in Cytometry and Molecular Biology, pp. 60-77; 1990 T. Brennan, J. Chakel, P. Bente, M. Field, "New Methods to Sequence DNA by Mass Spectrometry," IN: A. L. Burlingame and J. A. McCloskey (Eds.) Biological Mass Spectrometry, Elsevier, Amsterdam, pp. 159-177, which are incorporated herein by reference), and resonance ionization spectroscopy (RIS) (1979 G. S. Hurst, M. G. Payne, S. D. Kramer, J. P. Young, "Resonance ionization spectroscopy and one-atom detection", Rev. Mod Phys. 51:767-819; 1991 H. F. Arlinghaus, M. T. Spaar, N. Thonnard, A. W. McMahon, K. B. Jacobson, "Application of resonance ionization spectroscopy for semiconductor, environmental and biomedical analysis, and for DNA sequencing," SPIE Vol. 1435, Optical Methods for Ultrasensitive Detection and Analysis: Techniques and Applications, pp. 26-35; 1991 K. B. Jacobson, H. F. Arlinghaus, H. W. Schmitt, R. A. Sachleben, G.M. Brown, N. Thonnard, F. V. Sloop, R. S. Foote, F. W. Latimer, R. P. Woychik, M. W. England, K. L. Burchett, D. A. Jacobson, "An Approach to the Use of Stable Isotopes for DNA Sequencing," Genomics 9:51-59, which are incorporated herein by reference).

Another improvement which was developed from the original genomic sequencing methods is known as multiplex sequencing (Church and Kieffer-Higgins, 1988, Science 240:185-188, which is incorporated herein by reference). In multiplex sequencing, multiple sequencing reactions are pooled and electrophoresed together in a single gel to generate multiple superimposed sequencing ladders which are then transferred and bound to a nitrocellulose membrane. The membrane is then probed with an oligonucleotide which is specific for only one of the pools in order to reveal the corresponding ladder. By repeatedly stripping the membrane of probe and rehybridizing with different oligonhcleotides it is possible to obtain the sequence from each of the individual reactions. Although originally developed using radioactive isotopes to label the probes and therefore requiring lengthy autoradiographic exposures in order to visualize the ladder, newer multiplex sequencing protocols have been devised which employ chemiluminescent detection of the probes (Gillevet, 1990, Nature 348:657-658, which is incorporated herein by reference) or fluorescence detection (Yang and Youvan, 1989, Bio/Technology 7:576-580, which is incorporated herein by reference).

Mass spectrometry offers the potential of further improving ladder-based sequencing by also eliminating the electrophoresis step and replacing it with mass separation of conventional sequencing reaction mixtures using time-of-flight methods which require only milliseconds. Matrix-assisted laser desorption/ionization is currently being explored to generate mass ions as large as .about.300,000 daltons without fragmentation which might permit the determination of .about.600 bases. (1992 M. C. Fitzgerald, G. R. Parr, L. M. Smith, "DNA Sequence Analysis by Mass Spectrometry?" IN: Genome Mapping & Sequencing, Cold Spring Harbor Laboratory, Abstract #113; 1992 G. R. Parr, M. C. Fitzgerald, L. M. Smith, "Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry of Synthetic